Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN gastrointestinal disorder
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Scott Morris, Jesse Frey describe how UMSL is fostering entrepreneurship in latest episode of Inside UMSL podcast
Morris serves as the director of the Entrepreneurship and Innovation Center, and Frey, a marketing major, is the founder of Headlok.
MORE IN gastrointestinal disorder
LATEST NEWS
- Scott Morris, Jesse Frey describe how UMSL is fostering entrepreneurship in latest episode of Inside UMSL podcast
- Supply Chain master’s student Kabita Rokka lands job with Bruker Corporation
- UMSL Center for Character and Citizenship hosts Sen. Brian Williams and DESE Commissioner Karla Eslinger at Ed Collabitat
- Biology alum Chris Hollingsworth contributing to Saint Louis Zoo’s hellbender conservation and care team
- UMSL Tritons weekly rewind
- Student Pitch Competition offers students opportunity to showcase business ideas in contest with $5,000 first prize
- Eye on UMSL: Trash Bash
- May sociology graduate Triniti West explores passions for community and public policy
- Research and Innovation Celebration offers chance to recognize the impact of UMSL researchers
- MFA alum Serenity Dougherty’s PhD research examines stand-up comedy and audiences
